Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

332,318 Journal Article Views | Journal Analytics

Lorcaserin and the Role of 5-HT2C Agonism in the Treatment of Obesity

Submit a Paper



Publication Date: 19 Sep 2011

Type: Review

Journal: Clinical Medicine Reviews in Therapeutics

Citation: Clinical Medicine Reviews in Therapeutics 2011:3 347-354

doi: 10.4137/CMRT.S5768

Abstract

The serotonin (5-HT) system is implicated in the control of human appetite expression. However, previous serotonergic approaches to obesity, d-fenfluramine and sibutramine, were withdrawn over issues of safety. Selectively targeting hypothalamic 5-HT2C receptors should reduce the side effects produced by previous treatment. Lorcaserin is the first of a new generation of highly selective 5-HT2C agonists to pass through clinical development. Data is limited but the drug produces significant reductions in energy intake. These appear small compared to those reportedly produced by sibutramine and there is little evidence to indicate behavioural specificity or a clear satiety effect. However, Lorcaserin produces significant placebo-subtracted weight loss over two years of treatment which may be greater than current treatments such as the lipase inhibitor orlistat. Drugs that strengthen satiety may help individuals resist the urge to over-consume and maintain the reduction in energy intake required for successful weight control. However, for a number of patients Lorcaserin proved to be ineffective. For a centrally acting agent the drug's effect on appetite and behaviour remain poorly characterised. In summary, Lorcaserin produces statistically significant effects on energy intake, but the clinical significance of these findings is still debatable. Furthermore, the history of serotonin drugs indicates caution is warranted.


Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)






What Your Colleagues Say About Libertas Academica
testimonial_image
Working with the editorial staff and reviewers for Clinical Medicine Insights: Therapeutics was a positive experience.  The online submission/revision process was easy and staff were readily available to answer any questions.  Reviewers were knowledgeable, lending expert comments that allowed for improvement in content information.  I highly recommend others practitioners and researchers to consider Libertas Academica journals for their next publication.
LaNeigh Harkness (Texas Tech University Health Sciences Center, Lubbock, Texas, USA)
More Testimonials

Quick Links


Follow Us We make it easy to find new research papers.